Is Platelet-rich plasma superior to whole blood in the management of chronic tennis elbow: one year randomized clinical trial
In brief
Patients with chronic tennis elbow were randomised to a single injection of leukocyte-rich platelet-rich plasma (PRP) or of their own whole blood, with exercises and a strap for all. Both groups improved over a year, and the authors found PRP was not superior to autologous whole blood.
Read the original paper (opens in a new tab)
Citation, as listed in the PRP guidelines
Is Platelet-rich plasma superior to whole blood in the management of chronic tennis elbow: one year randomized clinical trial Authors: Seyed Ahmad Raeissadat, Seyed Mansoor Rayegani, Hossein Hassanabadi, Rosa Rahimi, Leyla Sedighipour, Khalil Rostami Link: https://www.ncbi.nlm.nih.gov/pubmed/24635909 Year of Publication: 2014
A summary of published research for general information. It does not replace a consultation; whether a treatment suits you is decided by a specialist after examination.
More from the PRP guidelines
- Autologous Peripheral Blood-Derived Orthobiologics for the Management of Elbow Disorders: A Review of Current Clinical Evidence2025
- Intra-articular injections of hyaluronic acid versus plasma rich in growth factors (PRGF) for knee osteoarthritis: a meta-analysis of randomised controlled trials2025
- Comparison of Platelet-Rich Plasma and Corticosteroid Injections for Chronic Plantar Fasciitis: A Randomized Controlled Trial2024
- The Safety and Effectiveness of Orthobiologic Injections for Discogenic Chronic Low Back Pain: A Multicenter Prospective, Crossover, Randomized Controlled Trial with 12 Months Follow-up2024

